TickerLeague

EBITDA for GE HealthCare (GEHC)

According to GE HealthCare's latest reported financial statements, the company's current EBITDA (TTM) is $3.58B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$3.58B

YoY change

+3.2%

5Y CAGR

+2.1%

Peak year (2025)

$3.79B

Cumulative EBITDA

$23.91B

EBITDA history chart for GE HealthCare (GEHC) from 2019 to 2025

EBITDA history table for GE HealthCare (GEHC) from 2019 to 2025

Fiscal yearPeriod endedReportedEBITDAYoY
2025$3.79B+3.2%
2024$3.67B+4.4%
2023$3.51B+11.0%
2022$3.17B-10.6%
2021$3.54B+3.9%
2020$3.41B+20.0%
2019$2.84B

EBITDA values are taken from GE HealthCare's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual EBITDA for GE HealthCare (GEHC) came in at $3.79B – edged up 3.2% year-over-year.

Looking at the 2020–2025 (5 years) stretch, GE HealthCare EBITDA compounded at +2.1% per year, sustaining 3 straight years of year-over-year growth.

2025 marks the peak EBITDA at $3.79B, with the historical low of $2.84B recorded in 2019.

Among 8 Healthcare peers, GE HealthCare (GEHC) ranks 9th; the peer median for EBITDA is $24.21B.

GE HealthCare EBITDA by Year

GE HealthCare EBITDA 2025: $3.79B

GE HealthCare EBITDA in 2025 was $3.79B, edged up 3.2% from 2024. This figure represents the highest annual value in the available history.

GE HealthCare EBITDA 2024: $3.67B

GE HealthCare EBITDA in 2024 was $3.67B, edged up 4.4% from 2023.

GE HealthCare EBITDA 2023: $3.51B

GE HealthCare EBITDA in 2023 was $3.51B, grew 11.0% from 2022.

GE HealthCare EBITDA 2022: $3.17B

GE HealthCare EBITDA in 2022 was $3.17B, declined 10.6% below 2021.

GE HealthCare EBITDA 2021: $3.54B

GE HealthCare EBITDA in 2021 was $3.54B.

See more financial history for GE HealthCare (GEHC).

Sector peers — EBITDA

Companies in the same sector as GE HealthCare, ranked by their latest EBITDA.

CompanyEBITDASector
Novo Nordisk A/S (NVO)$156.73BHealthcare
Johnson & Johnson (JNJ)$41.05BHealthcare
Eli Lilly and Company (LLY)$27.94BHealthcare
Merck & Co., Inc. (MRK)$25.36BHealthcare
UnitedHealth Group Incorporated (UNH)$23.06BHealthcare
AstraZeneca PLC (AZN)$19.83BHealthcare
AbbVie Inc. (ABBV)$17.63BHealthcare
Amgen Inc. (AMGN)$15.84BHealthcare

Frequently asked questions

What is GE HealthCare's EBITDA?

Latest reported EBITDA for GE HealthCare (GEHC) is $3.58B (period ending December 31, 2025).

How has GE HealthCare EBITDA changed year-over-year?

GE HealthCare (GEHC) EBITDA changed +3.2% year-over-year on the latest annual filing.

What is the long-term growth rate of GE HealthCare EBITDA?

GE HealthCare (GEHC) EBITDA compound annual growth rate is +2.1% over the most recent 5 years available.

When did GE HealthCare EBITDA hit its highest annual value?

GE HealthCare EBITDA reached its highest annual value of $3.79B in 2025.

What was GE HealthCare EBITDA in 2024?

GE HealthCare (GEHC) EBITDA in 2024 was $3.67B.

What was GE HealthCare EBITDA in 2025?

GE HealthCare (GEHC) EBITDA in 2025 was $3.79B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.